amotosalen has been researched along with Blood Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garban, F; Heddle, NM; McCullough, J; Rebulla, P; van der Meer, PF | 1 |
| Cazenave, JP; Corash, L; Defoin, L; Jacquet, M; Kientz, D; Lin, L; Liu, W; Mendel, I; Messe, N; Osselaer, JC; Propst, M; Sundin, D; Waller, C | 1 |
1 review(s) available for amotosalen and Blood Diseases
| Article | Year |
|---|---|
A crosswalk tabular review on methods and outcomes from randomized clinical trials using pathogen reduced platelets.
Topics: Blood Platelets; Disinfection; Furocoumarins; Hematologic Diseases; Humans; Neoplasms; Platelet Transfusion; Randomized Controlled Trials as Topic; Riboflavin; Ultraviolet Rays | 2020 |
1 trial(s) available for amotosalen and Blood Diseases
| Article | Year |
|---|---|
An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment.
Topics: Adult; Blood Component Transfusion; Child; Child, Preschool; Databases, Factual; Disinfection; Female; Furocoumarins; Hematologic Diseases; Humans; Infant; Male; Middle Aged; Plasma; Prospective Studies; Ultraviolet Rays | 2010 |